David Montani (Le Kremlin-Bicêtre, France), Paul Corris (Newcastle-upon-Tyne, United Kingdom)
LATE-BREAKING ABSTRACT: The effect of volume overload on pulmonary hypertension in hemodialysis patients
Süreyya Yilmaz (Diyarbakir, Turkey), Süreyya Yilmaz, Yasar Yildirim, Mahsuk Taylan, Melike Demir, Zülfükar Yilmaz, Aliveysel Kara, Fatma Aydin, Hadice Selimoglu Sen, Aziz Karabulut, Fusun Topcu
|   |
Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network
Sven Günther (Le Kremlin-Bicêtre, France), Sven Günther, Frédéric Perros, Benoit Ranchoux, Laurent Godinas, Fabrice Antigny, Marie-Camille Chaumais, Peter Dorfmüller, Aurélie Hautefort, Nicolas Raymond, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Gérald Simonneau, Marc Humbert, David Montani
| |
Characteristics and outcomes of heritable pulmonary veno-occlusive disease due to EIF2AK4 mutations
David Montani (Le Kremlin-Bicêtre, France), David Montani, Barbara Girerd, David Amar, Xavier Jais, Laurent Savale, Peter Dorfmuller, Jérome Lepavec, Mélanie Eyries, Florent Soubrier, Olivier Sitbon, Gérald Simonneau, Marc Humbert
| |
Chemotherapy-induced pulmonary hypertension: Role of alkylating agents
Frederic Perros (le Plessis-Robinson, France), Benoit Ranchoux, Sven Günther, Rozenn Quarck, Marie-Camille Chaumais, Peter Dorfmüller, Fabrice Antigny, Sébastian J. Dumas, Nicolas Raymond, Edmund Lau, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Gérald Simonneau, Kurt Stenmark, Sylvia Cohen-Kaminsky, Marc Humbert, David Montani, Frédéric Perros
| |
Pulmonary arterial lesions and interstitial remodeling patterns in histology differentiate EIF2AK4 mutation-carriers from non-carriers with pulmonary veno-occlusive disease
Esther Jeritza Nossent (Amsterdam, Netherlands), Esther Nossent, David Montani, Barbara Girerd, Frederic Perros, Florent Soubrier, Eli Fadel, Katrien Grünberg, Harm Jan Bogaard, Gerald Simonneau, Anton Vonk Noordegraaf, Marc Humbert, Peter Dorfmüller
| |
microRNA profile in COPD patients with and without pulmonary hypertension
Matthias Brock (Schlieren, Switzerland), Dinah Hertig, Caroline Leuenberger, Thomas Rechsteiner, Alex Soltermann, Silvia Ulrich, Walter Weder, Malcolm Kohler, Lars Huber, Matthias Brock
| |
Antiproliferative effects of drugs affecting different signalling pathways on rat and human pulmonary artery smooth muscle cells
Laura Moreno (Madrid, Spain), Daniel Morales-Cano, Bianca Barreira, Virginia Chamorro, Rachele Pandolfi, Beatriz De Olaiz Navarro, Andrés Esteban, Julio Cortijo, ángel Cogolludo, Laura Moreno, Francisco Pérez-Vizcaíno
| |
Children’s genetic screening in hereditary haemorrhagic telangiectasia - Read more: http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A3266
Ralph Epaud (Créteil, France), Ralph Epaud, Nurcan Soysal, Suzanne Verlhac, Melanie Eyrie, Marie-France Carette
| |
Epigenetic signature of right ventricular failure in pulmonary arterial hypertension
François Potus (Quebec, Canada), Francois Potus, Evangelos Michelakis, Steeve Provencher, Sébastien Bonnet
| |
Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension
Nuria Coll Bomfill (Barcelona, Spain), Nuria Coll-Bonfill, Melina Mara Musri, Nicholas Strieder, Jessica Garcia-Lucio, Isabel Blanco, Roberto Del pozo, Cristina Bonjoch, Victor Peinado, Joan Albert Barbera
| |
Cigarette smoking alters microRNA expression profiling and contributes to pulmonary artery remodeling via targeting connective tissue growth factor
Ran Wang (Hefei, China), Ran Wang, Gengyun Sun, Sijing Zhou
| |
Functional analysis of the 5´UTR region of BMPR2 gene in pulmonary arterial hypertension
Guillermo Pousada (Vigo, Spain), Guillermo Pousada, Sheila Castro-Sánchez, Adolfo Baloira, Diana Valverde
| |
Pulmonary arterial hypertension associated to HIV. Our experience
Daniela Gonzalez Marcano (Alicante, Spain), Daniela González Marcano, Rafael León Allocca, Joan Gil Carbonell, Raquel García Sevila, Concepción Martinez Serrano
| |
Elucidating signalling pathways in pulmonary hypertension using a microRNA knockout mouse model – In vitro and in vivo data
Neil McGlinchey (Clydebank, United Kingdom), Neil McGlinchey, Victor Samillan, Mariola Kurowska-Stolarska, Charles McSharry, Margaret Nilsen, Mandy MacLean, Andrew Peacock, David Welsh
| |
Functional characterization of BMPR2 gene in pulmonary arterial hypertension
Guillermo Pousada (Vigo, Spain), Guillermo Pousada, Vincenzo Lupo, María álvarez-Satta, Adolfo Baloira, Carmen Espinós, Diana Valverde
| |
HIV-associated pulmonary arterial hypertension onset is associated with the soluble CD14 level and inflammation related to monocyte activation by LPS translocation from the gut
Tasnime Issoufaly (Paris, France), Tasnime Issoufaly, David Zucman, Mehdi Ellouze, Sophie Hüe, Jean-Daniel Lelievre, Louis-Jean Couderc, Philippe Devillier, Veronique Godot, Colas Tcherakian
| |